FIKDX
Price
$12.30
Change
-$0.06 (-0.49%)
Updated
Aug 15 closing price
Net Assets
96.59M
VIVAX
Price
$70.33
Change
-$0.09 (-0.13%)
Updated
Aug 15 closing price
Net Assets
195.81B
Interact to see
Advertisement

FIKDX vs VIVAX

Header iconFIKDX vs VIVAX Comparison
Open Charts FIKDX vs VIVAXBanner chart's image
Kempner Multi-Cap Deep Value Instl
Price$12.30
Change-$0.06 (-0.49%)
VolumeN/A
Net Assets96.59M
Vanguard Value Index I
Price$70.33
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets195.81B
FIKDX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FIKDX vs. VIVAX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIKDX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 196B vs. FIKDX (96.6M). FIKDX (2.11) and VIVAX (2.06) have matching dividends . FIKDX was incepted earlier than VIVAX: FIKDX (17 years) vs VIVAX (33 years). FIKDX (0.97) is less costly to investors than VIVAX (0.17). FIKDX is a more actively managed with annual turnover of: 37.00 vs. VIVAX (9.00). VIVAX has a lower initial minimum investment than FIKDX: VIVAX (3000) vs FIKDX (500000). VIVAX annual gain was more profitable for investors over the last year : 7.90 vs. FIKDX (3.83). VIVAX return over 5 years is better than : 68.56 vs. FIKDX (43.10).
FIKDXVIVAXFIKDX / VIVAX
Total Expense Ratio0.970.17571%
Annual Report Gross Expense Ratio0.970.17571%
Fund Existence17 years33 years-
Gain YTD8.2476.512127%
Front LoadN/AN/A-
Min. Initial Investment500000300016,667%
Min. Initial Investment IRAN/AN/A-
Net Assets96.6M196B0%
Annual Yield % from dividends2.112.06102%
Returns for 1 year3.837.9049%
Returns for 3 years17.8825.9369%
Returns for 5 years43.1068.5663%
Returns for 10 years45.24114.6439%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LHCSX19.120.12
+0.63%
Lord Abbett Health Care R4
MCSSX39.37-0.09
-0.23%
NYLI WMC Enduring Capital Investor Class
ITHIX45.30-0.11
-0.24%
Hartford Capital Appreciation I
ASYLX15.82-0.05
-0.32%
AB Select US Long/Short Advisor
BISVX13.92-0.09
-0.64%
Brown Advisory Sustainable Val Inv